Graypoint LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 7.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,496 shares of the medical equipment provider’s stock after purchasing an additional 175 shares during the quarter. Graypoint LLC’s holdings in Intuitive Surgical were worth $1,226,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of ISRG. Mirador Capital Partners LP boosted its position in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. boosted its position in Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after acquiring an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock worth $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Brookstone Capital Management boosted its position in Intuitive Surgical by 22.4% during the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock worth $5,340,000 after acquiring an additional 2,289 shares during the last quarter. Finally, M&G Plc boosted its position in Intuitive Surgical by 53.5% during the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock worth $2,256,000 after acquiring an additional 1,766 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Trading Up 1.7 %
ISRG opened at $524.28 on Friday. The company has a fifty day simple moving average of $492.30 and a 200 day simple moving average of $450.05. The firm has a market cap of $186.74 billion, a price-to-earnings ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $269.49 and a twelve month high of $525.00.
Insider Activity at Intuitive Surgical
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on ISRG shares. Citigroup increased their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price target for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Morgan Stanley increased their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.
View Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Bank Stocks – Best Bank Stocks to Invest In
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How Investors Can Find the Best Cheap Dividend Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Stock Sentiment Analysis: How it Works
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.